Apothecary Pharma Llc: Apothecary Nad+ Injection 200 Mg/ml
Apothecary NAD+ Injection Recall Summary Apothecary Pharma LLC is recalling Apothecary NAD+ Injection 200 mg/mL (a prescription injectable medication) because the company cannot guarantee the product is sterile. The product was distributed nationwide across all 50 states. This is a Class II recall, meaning use of the product could cause serious adverse health effects.
- Recalling firm
- Apothecary Pharma LLC
- Product
- Apothecary NAD+ Injection 200 mg/mL, 6 mL Sterile Multi-Dose Vial, Rx Only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC, 27513, NDC 85091-011-06.
- Reason
- Lack of Assurance of Sterility
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-09-24
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- Nationwide within the United States
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/bdbe6b3b-9f43-4091-96d5-0a9601b19054